Pilot Study of Fosaprepitant (MK-0517) for Breakthrough Chemotherapy Induced Nausea and Vomiting

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01031953

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:35.233604+00:00

Published At

2014-01-30T00:00:00+00:00

Record Updated At

2017-05-09

Results Posted At

2014-01-30

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Breakthrough Nausea and Vomiting", "Unspecified Adult Solid Tumor, Protocol Specific"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-05-09"

protocolSection.identificationModule.nctId

"NCT01031953"

protocolSection.identificationModule.officialTitle

"Pilot Study of Fosaprepitant (MK-0517) for Breakthrough Chemotherapy Induced Nausea and Vomiting"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2014-01-30"

Study condition terms

• Breakthrough Nausea and Vomiting (protocolSection.conditionsModule.conditions)
• Unspecified Adult Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.